Dr. Reddy's Laboratories
RDY
#1841
Rank
A$16.17 B
Marketcap
A$19.27
Share price
1.13%
Change (1 day)
-13.76%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2025 (TTM): A$1.43 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are A$3.95 Billion. In 2024 the company made an earning of A$1.28 Billion, an increase over its 2023 earnings that were of A$1.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$1.43 B11.31%
2024 A$1.28 B7.01%
2023 A$1.20 B17.62%
2022 A$1.02 B43.27%
2021 A$0.71 B31.44%
2020 A$0.54 B54.54%
2019 A$0.35 B-14.21%
2018 A$0.41 B26.15%
2017 A$0.32 B4.69%
2016 A$0.31 B-55.7%
2015 A$0.70 B1.83%
2014 A$0.68 B-3.78%
2013 A$0.71 B54.07%
2012 A$0.46 B-16.23%
2011 A$0.55 B56.66%
2010 A$0.35 B-235.36%
2009 -A$0.27 Billion-198.53%
2008 A$0.26 B30.77%
2007 A$0.20 B-14.61%
2006 A$0.23 B703.63%
2005 A$29.57 M649.45%
2004 A$3.94 M-95.68%
2003 A$91.26 M-14.86%
2002 A$0.10 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$23.57 B 1,686.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$17.01 B 1,189.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.06 B 890.26%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
A$13.38 B 914.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$2.54 B 92.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel